These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. Maebashi K, Niimi M, Kudoh M, Fischer FJ, Makimura K, Niimi K, Piper RJ, Uchida K, Arisawa M, Cannon RD, Yamaguchi H. J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762 [Abstract] [Full Text] [Related]
12. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD. Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914 [Abstract] [Full Text] [Related]
13. Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans. Zhang X, Guo H, Gao L, Song Y, Li S, Zhang H. Pharm Biol; 2013 Jun; 51(6):749-52. PubMed ID: 23527892 [Abstract] [Full Text] [Related]
19. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump. Xu J, Liu R, Sun F, An L, Shang Z, Kong L, Yang M. Front Cell Infect Microbiol; 2019 Jun; 9():211. PubMed ID: 31281800 [Abstract] [Full Text] [Related]